TOPIC 2 Standards and Quality Variation Flashcards

WEEK 2

1
Q

are defined as documents that provide
requirements, specifications, guidelines, or characteristics
that can be used consistently to ensure that materials,
products, processes, and services are fit for their purpose

A

Quality standards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

defined as a list of tests, references to analytical procedures, and appropriate acceptance criteria, which are numerical limits, ranges, or other criteria for the tests described. ____ are critical quality standards that are proposed and justified by the manufacturer and approved by regulatory authorities as conditions of approval

A

Specification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

defined
as documents that provide
requirements, specifications,
guidelines, or characteristics that
can be used consistently to
ensure that materials, products,
processes, and services are fit for
their purpose. ___

A

Standards
(ASQ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is a list of detailed
requirements (acceptance
criteria for the prescribed test
procedures) with which the
substance or pharmaceutical
product has to conform to
ensure suitable quality.

A

Specification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

To avoid producing a defective
product, 1.__& 2. ___ are developed to
serve as basis for accepting or
rejecting a product.
Example of this is 3.___

A

Standards and Specifications

1-2. standards and
specifications
3. Drug Reference Standard
(RS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

is a standardized substance which is
used as a measurement base for similar
substances. Where the exact active
substances of a new drug are not known, a
reference standard provides a calibrated
level of biological effects against which new
preparations of the drug can be compared.

A

Drug Reference Standard
(RS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

This is concise and precise statement of the
ingredients that comprise the product, together with the
percentage and/or weight of each.

A

Formula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

This should enumerate
the characteristics of all the materials that go into the
product and the permissible range of purity of each
ingredient. Standard compendia like the USP, NF, BP,
BPC, Merck Index, etc., provide this valuable
information.

A

Raw Material Specification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

This is a
step by step method on how to go about a
job. It must spell out all information and
instructions that assure that variations in
production from day to day and week to
week will be held to within acceptable
established ranges.

A

Standard Operating Procedure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

This should
be set for everything that goes around the
product, i.e., bottles, cans, aluminum foil,
cellophane, jars, caps, cap liners, labels,
printed inserts, cartons, wrapping papers,
and shipping cases.

A

Packaging Material Standard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This
should cover all characteristics that affect
the proper performance, purity, safety and
stability of the product.

A

Finished Product Specification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

These are indispensable
in assuring conformity to standards. Since
they play such a vital role, testing
procedures must be standardized so that
they yield results of comparable precision
and accuracy in the hands of different
operators and laboratories. The tests must
be validated to ensure precision and
accuracy on application.

A

Testing Methods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the Official References: (primary)

A

v United States Pharmacopoeia and National Formulary
v Japan Pharmacopeia
v British Pharmacopeia
v European Pharmacopeia
v International Pharmacopeia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

is a legally
binding collection, prepared by a
national or regional authority of
standards and quality
specifications for medicines used
in that country or region

A

Pharmacopoeia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

a is used to furnish quality
specifications for active pharmaceutical
ingredients (APIs), FPPs and general
requirements.

A

Pharmacopoeia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

presents the basic assumptions,
definitions, and default conditions for the
interpretation and application of the USPNF

A

General Notices Section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Requirements stated apply to all
articles recognized in the USP and NF
and to all general chapters unless
specifically stated otherwise.

A

General Notices Section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

General Chapters 1 to 999

Example is 1.__

A

Physical tests and determinations,
microbiological tests, Chemical tests and
assays, Biological tests and assays

  1. ENFORCEABLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

General Chapters 1000 to 1999

A

General Information (no
mandatory requirement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

General Chapter Above 2000

A

apply to articles classified as
Dietary ingredient or supplements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

<1>

A

Injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

<2>

A

Oral Drug Products—Product Quality Tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

<231>

A

Heavy Metals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

<621>

A

Chromatography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
<671>
Containers
26
<761>
Nuclear Magnetic Resonance
27
<851>
Spectrophotometry
28
<781>
Optical Rotation
29
<1160>
Pharmaceutical Calculations in Prescription Compounding
30
<1176>
Prescription Balances and Volumetric Apparatus Used in Compounding:
31
<2232>
Elemental Contaminants in Dietary Supplements
32
<2750>
Manufacturing Practices for Dietary Supplements
33
is a combination of two official compendia:
The USP–NF 1-2. United States Pharmacopeia (USP) and the National Formulary (NF).
34
Monographs for drug substances and preparations are featured in the 1.__
1. USP
35
Monographs for 1-2. __ appear in a separate section of the USP.
1. dietary supplements and ingredients
36
Excipient monographs are found in the 1.___
NF.
37
Year of creation to signing of the first Philippine Pharmacopeia in cooperation with the Japanese Government through the initiatives of 2-3.___
1. 1996 2-3. Dr. Conrado S. Dayrit and Prof Akira Hamada.
38
1. When was the creation of Pharmacopeia Organization for the preparation and publication of the Phil Pharmacopeia thru _2_ 3. Declaring and adopting the Phil Pharmacopeia as the Official book of Standards nd Reference for Pharmaceutical Products and Crude plant drugs in the Philippines
1. May 26, 1999 2. Department Order no. 216-F 3. Exec. Order 302 (2004)
39
approved Standard Setting Organization or its foreign equivalent
1. ANSI Standards Setting Organization (SSO)
40
a government sponsored organization (where sponsorship is not based solely on financial contributions by the government), a multimember consortia or industry recognized organization Standards Setting Organization (SSO)
Standards Setting Organization (SSO)
41
(Guidelines: Norms and Standards for Pharmaceuticals)
WHO
42
Current Good Manufacturing Practice (CGMP) Regulations
FDA
43
Adoption and Implementation of the Pharmaceutical Inspection and Scheme )PIC/S) Guides for the Good manufacturing practice for medicinal products
AO 2012 – 0008
44
Guidelines for The Classification of Deficiencies Observed During Inspection of Drug Manufacturers
Circular No.2019-003
45
is the leading the international development, implementation and maintenance of harmonized GMP standards and quality systems of Inspectorates in the field of medicinal products
PIC/S - Pharmaceutical Inspection Cooperation Scheme Guides ◎ICH - International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use:
46
Establish a uniform set of standards for drug registration non-profit Association under Swiss law on 2.___
1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 2. October 23, 2015
47
Brings the regulatory authorities and pharmaceutical industry to discuss about scientific and technical aspects about drug registration.
International Council for Harmonisation
48
Reduction of unnecessary animal testing without compromising safety and effectiveness accomplished through 1.__ that are implemented by the regulatory authorities.
Technical Guidelines
48
Main goal of International Council for Harmonisation is to
achieve greater harmonization worldwide.
48
ICH - Purpose Promotion of public health through international harmonisation that contributes to: 1-4.
* Prevention of unnecessary duplication of clinical trials and post market clinical evaluations * Development and manufacturing of new medicines * Registration and supervision of new medicines * Reduction of unnecessary animal testing without compromising safety and effectiveness accomplished through Technical Guidelines that are implemented by the regulatory authorities
49
ICH – Founding members 1-5.
1. Europe 2. European Commission 3. Japan 4. Ministry of Health, Labor and Welfare (MHLW) 5. or Pharmaceuticals and Medical Devices Agency (PMDA) US
50
ICH – Standing Observers
1. WHO 2. International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Observers Regulatory authorities Regional Harmonisation Initiatives international industry pharmaceutical organisations international organisations regulated or affected by ICH Guidelines
51
Clinical trials conducted in one ICH region can be used in other ICH regions by setting the common standards on science and ethics.
GCP (Good Clinical Practice)
52
brings together all Quality, Safety and Efficacy information in a common, harmonised format, accepted by regulators in all ICH regions. It has revolutionised regulatory review processes for regulators and industry.
CTD/eCTD (Common Technical Document)
53
Highly specific, standardised medical terminology developed by ICH to facilitate sharing of regulatory information
MedDRA (Medical Dictionary for Regulatory Activities)
54
It is used for registration, documentation and safety monitoring of medical products both before and after marketing authorisation
MedDRA (Medical Dictionary for Regulatory Activities)
55
ICH Guidelines
› Quality – 14 Guidelines › Safety - 23 Guidelines › Efficacy – 21 Guidelines › Multidisciplinary - 6 Guidelines
56
14 Guidelines
Quality
57
Safety - 23 Guidelines
Safety
58
21 Guidelines
Efficacy
59
6 Guidelines
Multidisciplinary
60
stability studies, defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical quality
Quality
61
potential risks like carcinogenicity, genotoxicity and reprotoxicity
Safety
62
conduct, safety and reporting of clinical trials
Efficacy
63
ICH medical terminology (MedDRA), the Common Technical Document (CTD) and the development of Electronic Standards for the Transfer of Regulatory Information (ESTRI).
Multidisciplinary
64
Q S E M
QUALITY SAFETY EFFICACY MULTIDISCIPLINARY
65
Q4B-Annex 7
Dissolution Test General Chapter
66
ICH QUALITY GUIDELINES
1. Finished Product Control Compendial Requirements for Liquid and Solid Dosage Forms (ICH Q6) 2. Statistical Quality Control (ICH Q9, Annex I.9- Supporting Statistical Tools) 3. Stability Studies (ICH Q1) 4. Validation (ICH Q2)
67
(ICH Q6)
Finished Product Control Compendial Requirements for Liquid and Solid Dosage Form
68
(ICH Q9, Annex I.9- Supporting Statistical Tools)
Statistical Quality Control
69
(ICH Q1)
Stability Studies
70
is an undesirable characteristic of a product.
defect
71
(ICH Q2)
Validation
72
It is defined as a failure to conform to specifications.
defect
73
A unit of a product which contains one or more defects is called a ___.
defective
74
Any unwanted event that represents a departure from approved processes or procedures or instruction or specification or established standard or from what is required. Deviations can occur during manufacturing, packing, sampling and testing of drug products.
Deviation
75
change in data, expected outcomes, or slight changes in production quality
VARITION
76
Examples of Defects: 1-13
› Mottling › Chipping › Lamination › Telescoping › Caking › Coalescence › Creaming › Off-color › Capping - wrong volume - missing label - misplaced dropper - sub potent
77
– a defect which can be measured directly by instruments. Examples are: 1-8
Variable defect Ex. length, weight, height, thickness, concentration, volume, viscosity, pH or size particles.
78
– a defect which cannot be measured directly by instruments. It shows mainly the conformance or nonconformance. Examples are: 1-6
Attribute defect Ex. Functional, Texture, presence of dents, cracks, missing buttons, cracks
79
Attribute defect can be ___
Counted
80
a defect which may endanger life or property and may render the product non – functional. Examples are: 1.
Critical defect Ex: Absence of a warning in a label for a potent drug or disintegration time of one hour for an analgesic.
80
a defect which may affect the function of the object and therefore, may render the product useless or aesthetically objectionable
Major defect Ex: Presence of a crack in a bottle.
81
Stains that may appear
Major defect
82
a defect which does not endanger life or property nor will it affect the function but nevertheless remains a defect since it is outside the prescribed limits. Examples are: 1
Minor defect Ex: slight deviation of the color of the label from the color standards.
83
Scratches or dents
Minor defect
83
What are defect According to measurability: 1-2
Variable defect Attribute defect
84
According to seriousness or gravity:
Critical defect Major defect Minor defect
85
According to nature:
Ocular defect Internal defect Performance defect
85
a defect that is visible.
Ocular defect e.g., foreign particulate contamination.
86
a defect which is not seen although present.
Internal defect e.g., a sub – potent drug product.
87
a defect in function.
Performance defect e.g., suppository that does not melt at body temperature.
88
is the method of withdrawing or correcting unsafe or hazardous health products from the distribution chain that may present a health hazard to the consumer or user.
Recall
89
a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
Class I recall
90
a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Class II recall
91
a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences
Class III recall
92
Class I Pathogens:
I- Salmonella, Listeria monocytegenes, E. coli, Clostridium
93
Class II Pathogens:
II – Shigella, Cyclospora, Cryptosporidium, hepatitis A
94
Class III Pathogens:
III – Low levels of pesticide residue
95
Type of Defects Adverse reactions related to a product defect.
}Packaging, bottling/filling and labelling. }Deviations from specifications }Contamination }Packaging defects
96
Other deviations: Other deviations typically concern reports of non-compliance with GMP, counterfeit medicines, authorized variation applications and the suspension of marketing authorizations leading to withdrawals, as well as defects related to the product itself, e.g. precipitation,
97
Product Recall Examples:
› wrong (potent) product (label and contents are different products) with serious medical consequences › chemical or microbial contamination with serious medical consequences or in sterile preparations › wrong active ingredient in a multi-component product with serious medical consequences. › Defective pacemaker, defibrillator › Hot/cold packs containing toxic substances › Software and hardwares (used for critical conditions) defects
98
Product Recall Examples:
› mislabeling (for example, incorrect or missing text or figures) › non-compliance with specification, such as in an assay, stability, fill or weight resulting in medical consequences › insecure or incorrect closures for medicines such as cytotoxics, potent products and medicines requiring child-resistant packaging resulting in medical consequences. › faulty packaging, such as wrong or missing batch number or expiry date › faulty closure not resulting in any medical consequences › contamination with no medical consequences
99
Sources and Control of Quality Variation manufacturing processes become more complex -->
The risk of errors increases
100
material control, GMP, packaging control, automation and statistical sampling plans are employed -->
To minimize and eliminate the sources of errors which can cause product quality variation
101
Sources of Variation:
materials machines methods men
102
Variation between suppliers of same substance.
materials
103
Variation of equipment for the same process.
machines
104
Inexact procedures.
methods
105
Variation between batches from same supplier.
materials
106
Aging and improper care.
machines
106
Negligence by chance.
methods
107
Inadequate procedures.
methods
107
Difference in adjustment of equipment.
machines
108
Variation within a batch.
materials
109
Improper working conditions.
men
110
Inadequate training, and understanding.
men
111
Dishonesty, fatigue and carelessness.
men
112
a visualization tool for categorizing the potential causes of a problem in order to identify its root causes.
113
A fishbone diagram,____ diagram or Ishikawa diagram
“cause and effect”
114
› Dr. Kaoru Ishikawa, a Japanese quality control expert: 1-2
Quality improvement is a continuous process Customer continued service
115
4P's
(Policies, Procedures, People and Plant
116